{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:22:04Z","timestamp":1713226924048},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,14]]},"DOI":"10.7759\/cureus.58277","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:52:51Z","timestamp":1713163971000},"source":"Crossref","is-referenced-by-count":0,"title":["Emergency Department Utilization by Pediatric Patients With Sickle Cell Disease in Basrah, Iraq"],"prefix":"10.7759","author":[{"given":"Ahmed S","family":"Marroof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaad K","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20120041","article-title":"Sickle cell disease: looking back but towards the future","volume":"34","author":"Can\u00e7ado RD","year":"2012","unstructured":"Can\u00e7ado RD. Sickle cell disease: looking back but towards the future. Rev Bras Hematol Hemoter. 2012, 34:175-7. 10.5581\/1516-8484.20120041","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/hemato3020024","article-title":"Sickle cell disease, a review","volume":"3","author":"Tebbi CK","year":"2022","unstructured":"Tebbi CK. Sickle cell disease, a review. Hemato. 2022, 3:341-66. 10.3390\/hemato3020024","journal-title":"Hemato"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.26719\/2003.9.1-2.45","article-title":"Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra","volume":"9","author":"Hassan MK","year":"2003","unstructured":"Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J. 2003, 9:45-54.","journal-title":"East Mediterr Health J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100983","article-title":"Determinants of severity in sickle cell disease","volume":"56","author":"Rees DC","year":"2022","unstructured":"Rees DC, Brousse VA, Brewin JN. Determinants of severity in sickle cell disease. Blood Rev. 2022, 56:100983. 10.1016\/j.blre.2022.100983","journal-title":"Blood Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5772\/62012","article-title":"Introduction to the history, pathology and clinical management of sickle cell disease","volume":"1","author":"Inusa B","year":"2016","unstructured":"Inusa B, Casale M, Ward N. Introduction to the history, pathology and clinical management of sickle cell disease. IntechOpen. 2016, 1:846-60. 10.5772\/62012","journal-title":"IntechOpen"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.08.009","article-title":"Sickle cell disease in the emergency department","volume":"31","author":"Lovett PB","year":"2017","unstructured":"Lovett PB, Sule HP, Lopez BL. Sickle cell disease in the emergency department. Hematol Oncol Clin North Am. 2017, 31:1061-79. 10.1016\/j.hoc.2017.08.009","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303773","article-title":"Sickle cell disease: a neglected chronic disease of increasing global health importance","volume":"100","author":"Chakravorty S","year":"2015","unstructured":"Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. 2015, 100:48-53. 10.1136\/archdischild-2013-303773","journal-title":"Arch Dis Child"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2012.01330.x","article-title":"Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management","volume":"19","author":"Tanabe P","year":"2012","unstructured":"Tanabe P, Hafner JW, Martinovich Z, Artz N. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. Acad Emerg Med. 2012, 19:430-8. 10.1111\/j.1553-2712.2012.01330.x","journal-title":"Acad Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002%2Fpbc.22979","article-title":"Sickle cell disease in California: sociodemographic predictors of emergency department utilization","volume":"58","author":"Wolfson JA","year":"2012","unstructured":"Wolfson JA, Schrager SM, Khanna R, Coates TD, Kipke MD. Sickle cell disease in California: sociodemographic predictors of emergency department utilization. Pediatr Blood Cancer. 2012, 58:66-73. 10.1002%2Fpbc.22979","journal-title":"Pediatr Blood Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07461-6","article-title":"Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country","volume":"22","author":"Lobo C","year":"2022","unstructured":"Lobo C, Moura P, Fidlarczyk D, et al.. Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country. BMC Health Serv Res. 2022, 22:42. 10.1186\/s12913-021-07461-6","journal-title":"BMC Health Serv Res"},{"key":"ref11","article-title":"Quality of life determinants in people with epilepsy in Basrah, Iraq","volume":"12","author":"Shakir M","year":"2012","unstructured":"Shakir M, Al-Asadi JN. Quality of life determinants in people with epilepsy in Basrah, Iraq. Sultan Qaboos Uni Med J. 2012, 12:457-9.","journal-title":"Sultan Qaboos Uni Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-012-0217-z","article-title":"Sickle cell anemia from central India: a retrospective analysis","volume":"49","author":"Jain D","year":"2012","unstructured":"Jain D, Italia K, Sarathi V, Ghoshand K, Colah R. Sickle cell anemia from central India: a retrospective analysis. Indian Pediatr. 2012, 49:911-3. 10.1007\/s13312-012-0217-z","journal-title":"Indian Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/949535","article-title":"Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management","volume":"2012","author":"Ballas SK","year":"2012","unstructured":"Ballas SK, Kesen MR, Goldberg MF, et al.. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal. 2012, 2012:949535. 10.1100\/2012\/949535","journal-title":"ScientificWorldJournal"},{"key":"ref14","article-title":"Division of Blood Diseases and Resources. The management of sickle cell disease","volume":"29","year":"2002","unstructured":"Division of Blood Diseases and Resources. The management of sickle cell disease. NIH Publications. 2002, 29.","journal-title":"NIH Publications"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/2384-5589.170158","article-title":"Sickle cell anaemia: morbidity profile and outcome in a paediatric emergency setting in Nigeria","volume":"79","author":"Abhulimhen-Iyoha BI","year":"201514","unstructured":"Abhulimhen-Iyoha BI, Israel-Aina YT, Joel-Utomakili K. Sickle cell anaemia: morbidity profile and outcome in a paediatric emergency setting in Nigeria. Afr J Med Health Sci. 201514, 79:82. 10.4103\/2384-5589.170158","journal-title":"Afr J Med Health Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2016.07.005","article-title":"Hospitalizations of children with sickle cell disease in the Brazilian Unified Health System in the state of Minas Gerais","volume":"93","author":"Fernandes AP","year":"2017","unstructured":"Fernandes AP, Avendanha FA, Viana MB. Hospitalizations of children with sickle cell disease in the Brazilian Unified Health System in the state of Minas Gerais. J Pediatr (Rio J). 2017, 93:287-93. 10.1016\/j.jped.2016.07.005","journal-title":"J Pediatr (Rio J)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4314\/njp.v40i1.6","article-title":"Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria","volume":"40","author":"Brown BJ","year":"2013","unstructured":"Brown BJ, Jacob NE, Lagunju IA, Jarrett OO. Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria. Niger J Paed. 2013, 40:34-9. 10.4314\/njp.v40i1.6","journal-title":"Niger J Paed"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2015.03.013","article-title":"Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil","volume":"37","author":"Fernandes TA","year":"2015","unstructured":"Fernandes TA, Medeiros TM, Alves JJ, et al.. Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil. Rev Bras Hematol Hemoter. 2015, 37:172-7. 10.1016\/j.bjhh.2015.03.013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100158","article-title":"Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020","volume":"3","author":"Attell BK","year":"2024","unstructured":"Attell BK, Barrett PM, Pace BS, et al.. Characteristics of Emergency Department Visits Made by Individuals With Sickle Cell Disease in the U.S., 1999-2020. AJPM Focus. 2024, 3:100158. 10.1016\/j.focus.2023.100158","journal-title":"AJPM Focus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00140","article-title":"Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study","volume":"6","author":"Ceglie G","year":"2019","unstructured":"Ceglie G, Di Mauro M, Tarissi De Jacobis I, et al.. Gender-related differences in sickle cell disease in a pediatric cohort: a single-center retrospective study. Front Mol Biosci. 2019, 6:140. 10.3389\/fmolb.2019.00140","journal-title":"Front Mol Biosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3324%2Fhaematol.2014.120030","article-title":"Environmental determinants of severity in sickle cell disease","volume":"100","author":"Tewari S","year":"2015","unstructured":"Tewari S, Brousse V, Piel FB, Menzel S, Rees DC. Environmental determinants of severity in sickle cell disease. Haematologica. 2015, 100:16. 10.3324%2Fhaematol.2014.120030","journal-title":"Haematologica"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1195040","article-title":"Management of fever and acute painful crises in children with sickle cell disease in emergency departments: a tertiary hospital experience","volume":"11","author":"Almahmoud T","year":"2023","unstructured":"Almahmoud T, Alnashwan T, Al Kuhaimi L, Essa MF, Al Balawi N, Jamaan KA, Al-Harthy N. Management of fever and acute painful crises in children with sickle cell disease in emergency departments: a tertiary hospital experience. Front Pediatr. 2023, 11:1195040. 10.3389\/fped.2023.1195040","journal-title":"Front Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/TME.0000000000000106","article-title":"Shift in emergency department provider attitudes toward patients with sickle cell disease","volume":"38","author":"Freiermuth CE","year":"2016","unstructured":"Freiermuth CE, Silva S, Cline DM, Tanabe P. Shift in emergency department provider attitudes toward patients with sickle cell disease. Adv Emerg Nurs J. 2016, 38:199-212. 10.1097\/TME.0000000000000106","journal-title":"Adv Emerg Nurs J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/0009922816674521","article-title":"Pain management for sickle cell disease in the pediatric Emergency Department: medications and hospitalization trends","volume":"56","author":"Cacciotti C","year":"2017","unstructured":"Cacciotti C, Vaiselbuh S, Romanos-Sirakis E. Pain management for sickle cell disease in the pediatric Emergency Department: medications and hospitalization trends. Clin Pediatr (Phila). 2017, 56:1109-14. 10.1177\/0009922816674521","journal-title":"Clin Pediatr (Phila)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005406.pub5","article-title":"Fluid replacement therapy for acute episodes of pain in people with sickle cell disease","volume":"7","author":"Okomo U","year":"2017","unstructured":"Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev. 2017, 7:CD005406. 10.1002\/14651858.CD005406.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007%2Fs12288-013-0261-4","article-title":"Hydroxyurea in sickle cell disease: drug review","volume":"30","author":"Agrawal RK","year":"2014","unstructured":"Agrawal RK, Patel RK, Shah V, Lalit Nainiwal L, Trivedi B. Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus. 2014, 30:91-6. 10.1007%2Fs12288-013-0261-4","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00038","article-title":"Life-threatening infectious complications in sickle cell disease: a concise narrative review","volume":"8","author":"Ochocinski D","year":"2020","unstructured":"Ochocinski D, Dalal M, Black LV, Carr S, Lew J, Sullivan K, Kissoon N. Life-threatening infectious complications in sickle cell disease: a concise narrative review. Front Pediatr. 2020, 8:38. 10.3389\/fped.2020.00038","journal-title":"Front Pediatr"},{"key":"ref28","article-title":"Morbidity pattern in hospitalized under five children with sickle cell disease","volume":"138","author":"Jain D","year":"2013","unstructured":"Jain D, Bagul AS, Shah M, Sarathi V. Morbidity pattern in hospitalized under five children with sickle cell disease. Indian J Med Res. 2013, 138:317-21.","journal-title":"Indian J Med Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau DC","year":"2010","unstructured":"Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010, 303:1288-94. 10.1001\/jama.2010.378","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002%2Fpbc.21854","article-title":"Risk factor for hospital readmission within 30-days: a new quality measure for children with sickle cell disease","volume":"52","author":"Frei-Jones MJ","year":"2009","unstructured":"Frei-Jones MJ, Field JJ, DeBaun MR. Risk factor for hospital readmission within 30-days: a new quality measure for children with sickle cell disease. Pediatr Blood Cancer. 2009, 52:481-5. 10.1002%2Fpbc.21854","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/238123-emergency-department-utilization-by-pediatric-patients-with-sickle-cell-disease-in-basrah-iraq","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:52:55Z","timestamp":1713163975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/238123-emergency-department-utilization-by-pediatric-patients-with-sickle-cell-disease-in-basrah-iraq"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.58277","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,14]]}}}